// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A multicentre trial on the performance of a two‐step triage protocol based on initial serum progesterone and serial hCG used to manage pregnancies of unknown location (PUL)

S. Bobdiwala - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of ovarian masses during pregnancy in a London university hospital: a cohort study

S. Saso - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An AI system to support sonologists during fetal ultrasound anomaly screening

M. Yaqub - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact and uptake of ISUOG's Basic Training Program

T.E. Cohen-Overbeek - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perinatal mortality and morbidity in twin pregnancies with selective fetal growth restriction according to their management: a meta‐analysis

R. Townsend - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

The predictive accuracy of the STORK chorionicity‐specific twin growth charts for stillbirth: a validation study

E. Kalafat - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A preoperative risk model with ultrasound variables to assess lymph node metastasis in endometrial cancer patients: a model development and validation study by the IETA group

L. Eriksson - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

*The efficacy of preoperative ultrasound in detecting uterine sarcoma prior to myomectomy

E. Bean - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm

L. Poon - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

*Deep endometriosis assessment on ultrasound and MRI as defined by international deep endometriosis analysis (IDEA) group (diagnostic accuracy study)

T. Indrielle-Kelly - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Pelvic vein thrombosis and associated pelvic abnormalities

T. Amin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Macrosomia: a self‐fulfilling prophecy

L. Levitt - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

N/A

N/A

Is the presence or absence of intracavity fluid associated with a final diagnosis of ectopic pregnancy in women with a pregnancy of unknown location?

K. Grewal - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Evaluating cut‐off values for progesterone, single hCG and hCG ratio to define pregnancy viability and location in women with a pregnancy of unknown location (PUL)

S. Bobdiwala - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Accuracy of prediction of hemoperitoneum in ectopic pregnancy

K. Rajah - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Impact of intrauterine hematoma on pregnancy outcomes

M. Al-Memar - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Image review for quality of the first trimester anomaly scan

J. Karim - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Who is at risk of endometrial cavity breach at laparoscopic myomectomy?

K. Rajah - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Can ovarian reserve predict the chances of live birth after one complete cycle of IVF and transfer of all frozen embryos?

N. Balachandren - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Maternal uterine and fetal umbilical artery Doppler impedance is associated with maternal hemodynamic function

J. Tay - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved